Research Article| Volume 1, ISSUE 2, P181-198, June 1981

Download started.


Current Status of Alpha-Fetoprotein Testing

  • James N. Macri
    Department of Obstetrics and Gynecology, State University of New York, Stony Brook, New York 11794
    Research Assistant Professor, and Director, Neural Tube Defect Laboratory, Department of Obstetrics and Gynecology, State University of New York, Stony Brook, New York
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      The alpha-fetoprotein screening test for neural tube defects can provide specific information on the condition of an unborn fetus and can offer reassurance to families at increased risk for these defects. However, additional studies to document safety and effectiveness of this procedure in various settings are needed. Proper implementation of an AFP testing program in the United States has the potential to enhance maternal-fetal well-being.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Antenatal Diagnosis: Report of a Consensus Development Conference. Sponsored by the National Institute of Child Health and Human Development, National Institutes of Health Publication No. 79-1973, March 5-7, 1979

        • Brock D.J.H.
        • Bolton A.E.
        • Monaghan J.M.
        Prenatal diagnosis of anencephaly through maternal serum-Alpha-fetoprotein measurement.
        Lancet. 1973; 2: 923
      2. Department of Health and Human Services: Alpha-fetoprotein test kits: Proposed restrictions and proposed additional quality control and testing requirements. Federal Register, Vol. 45, No. 218, November 7, 1980

        • Ishiguro T.
        Alpha-fetoprotein in twin pregnancy.
        Lancet. 1973; 2: 1214
        • Macri J.N.
        • Weiss R.R.
        • Starkovsky N.A.
        • et al.
        Maternal serum alpha-fetoprotein and prospective screening.
        Lancet. 1975; 2: 719
        • Macri J.N.
        • Weiss R.R.
        • Tillitt R.
        • et al.
        Prenatal diagnosis of neural tube defects.
        J.A.M.A. 1976; 236: 1251
        • Macri J.N.
        • Haddow J.E.
        • Weiss R.R.
        Screening for neural tube defects in the United States: A summary of the Scarborough conference.
        Am. J. Obstet. Gynecol. 1979; 133: 119
        • Macri J.N.
        • Weiss R.R.
        • Libster B.
        Maternal serum alpha-fetoprotein screening for neural tube defects: Structure and organization.
        in: Porter I.H. Hook E.B. Service and Education in Medical Genetics. Academic Press, New York1979: 221
        • Macri J.N.
        • Weiss R.R.
        Prenatal detection of neural tube defects.
        Semin. Perinatol. 1980; 4: 207
        • Macri J.N.
        Amniotic fluid alpha-fetoprotein evaluation.
        in: Gastel B. Haddow J. Fletcher J.C. Maternal Serum Alpha-Fetoprotein: Issues in the Prenatal Screening and Diagnosis of Neural Tube Defects. Superintendent of Documents, United States Government Printing Office, Washington, D.C.1980: 15 (eds.)
      3. Report of the ACOG/AAP Alpha-Fetoprotein Task Force: August 3, 1979

        • Ruoslahti E.
        • Seppala M.
        Radioimmunoassay of α-fetoprotein.
        in: Abraham G. Handbook of Radioimmunoassay. Inc., New York, Marcel Dekker1977: 543
        • Sizaret P.P.
        • Mclntire K.R.
        • Princler G.
        Quantitation of human α-fetoprotein by electroimmunodiffusion.
        Cancer Res. 1971; 31: 1899
        • Smith A.D.
        • Wald N.J.
        • Cuckle H.S.
        • et al.
        Amniotic fluid acetylcholinesterase as a possible diagnostic test for neural tube defects in early pregnancy.
        Lancet. 1979; 1: 685
        • Swinyard C.A.
        • Chaube S.
        • Nishimura H.
        Spina bifida as a prototype defect for decision making.
        in: Swinyard C. Decision Making and the Defective Newborn. Charles C Thomas, Springfield, Illinois1978: 17
      4. Towards the prevention of spina bifida.
        Lancet. 1974; 1: 907
        • Weiss R.R.
        • Macri J.N.
        • Elligers K.W.
        • et al.
        Amniotic fluid α-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
        Obstet. Gynecol. 1975; 47: 148
        • Weiss R.R.
        • Macri J.N.
        • Elligers K.W.
        Origin of amniotic fluid alpha-fetoprotein in normal and defective pregnancies.
        Obstet. Gynecol. 1976; 47: 697